Operating income increased 119.6%
Operating income changed +119.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating income changed +119.6% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
Inventory changed +300.5% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Research & development changed +173.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Gross margin changed -1965 basis points from the comparable as-filed period.
Revenue changed +156.5% from the comparable as-filed period.
Operating margin changed -709 basis points from the comparable as-filed period.
Net income changed +31.1% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Stock-based compensation changed +52.6% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
Cash & equivalents changed +61.1% from the comparable as-filed period.
Gross profit changed +103.6% from the comparable as-filed period.
Inventory / revenue changed +1361 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.